Bradshaw urges generics industry to support user fees

Share this content:
Days after resigning to join the law firm of Hunton & Williams, FDA chief counsel Sheldon Bradshaw took advantage of his sudden freedom to strongly urge the generic drug industry to support user fees as the best means for reducing the review backlog at the agency. More funding for this from the administration is unlikely, he said.
Share this content:
Scroll down to see the next article